Lilly launches lower-price weight loss drug without injector pen - CNN
Aug 27, 2024 · Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply ...
Zepbound: The newest obesity medication explained by an expert - CNN
Nov 14, 2023 · The US Food and Drug Administration approved the medication Zepbound last week to treat chronic obesity. The injectable drug, made by the pharmaceutical company Eli Lilly, has the active...
News Release - Eli Lilly and Company
INDIANAPOLIS, Aug. 27, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Zepbound ® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand.
Zepbound price cut: Eli Lilly lowers cost of weight loss drug - NBC News
Aug 27, 2024 · Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply ...
News Release - Eli Lilly and Company
Nov 8, 2023 · Zepbound is the first and only approved treatment activating two incretin hormone receptors, GIP and GLP-1, to tackle an underlying cause of excess weight.
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
Nov 8, 2023 · Zepbound is the second drug in a new class of obesity medications to be approved for weight loss, following Wegovy. And it is now likely the most effective treatment to combat obesity besides...
Weight loss drug Zepbound is now available, Eli Lilly says
Dec 6, 2023 · CNN — Drug manufacturer Eli Lilly announced Tuesday that its flagship weight loss medication, Zepbound, is now available for patient use. Tirzepatide, its active ingredient, had been approved by...
What to know about Zepbound, Eli Lilly’s new weight loss drug - NBC News
Nov 9, 2023 · The Food and Drug Administration approved Zepbound for use by adults with a body mass index, or BMI, of at least 30 or a BMI of 27 or more if a patient also has another weight-related condition,...
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...
Zepbound: Eli Lilly releases new, cheaper form of weight loss drug
Aug 27, 2024 · Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage …